The influence of lipoprotein lipase gene polymorphisms on coronary artery disease and plasma lipids in Zagreb cohort (CROSBI ID 494165)
Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Pašalić, Daria ; Ferenčak, Goran ; Gršković, Branka ; Cheng, Suzanne ; Fijal, Bonnie ; Šesto, Mihajlo ; Skodlar, Jasna ; Stavljenić Rukavina, Ana
engleski
The influence of lipoprotein lipase gene polymorphisms on coronary artery disease and plasma lipids in Zagreb cohort
We investigated the relationship between lipoprotein lipase (LPL) gene polymorphisms (-93 T/G, D9N, N291S, and S447X), coronary artery disease (CAD) and lipid traits. We examined Croatian patients with (n=497) and without (n=200) angiographically confirmed CAD. The N291S polymorphism was significantly associated with CAD (OR: 0.36 ; p: 0.048). HLD2-cholesterol and apolipoprotein A I levels were significantly higher in non-carriers of the -93T/G and D9N polymorphisms in the CAD group (p: 0.017 and 0.028, respectively). The N291S genetic variant did not show any significant difference between carriers and non-carriers in the both groups studied for any of the lipids. Lower triglyceride and higher HDL2-cholesterol levels in the control group were associated with carriers of the S447X mutation (p: 0.043 and 0.056, respectively). We conclude that modification in lipoprotein lipase gene might influence lipid levels, and confer risk for CAD.
lipoprotein lipase ; genetic polymorphism ; coronary artery disease
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
S330-S330.
2003.
nije evidentirano
objavljeno
Podaci o matičnoj publikaciji
Clinical chemistry and laboratory medicine
1434-6621
Podaci o skupu
EUROMEDLAB Barcelona 2003
poster
01.01.2003-01.01.2003
Barcelona, Španjolska